Recombinant MS4A1 (Ibritumomab Biosimilar) anticorps

N° du produit ABIN7488261

Cet anticorps Mammalian Cells Monoclonal détecte spécifiquement MS4A1 (Ibritumomab Biosimilar) dans ELISA. Il présente une réactivité envers Humain.

Aperçu rapide pour Recombinant MS4A1 (Ibritumomab Biosimilar) anticorps (ABIN7488261)

Antigène: MS4A1 (Ibritumomab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Mammalian Cells

Clonalité: Monoclonal

Conjugué: Cet anticorp MS4A1 (Ibritumomab Biosimilar) est non-conjugé

Application: ELISA

Classe de qualité: Research Grade

Détail du produit anti-MS4A1 (Ibritumomab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Ibritumomab Biosimilar - Anti-MS4A1(CD20,MS4A-1) mAb

Attributs du produit: Antibody Type: Human IgG2A

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Buffer: PBS pH 7.5

Stock: -80 °C

Stockage commentaire: store at -80°C

Détails sur MS4A1 (Ibritumomab Biosimilar)

Antigène: MS4A1 (Ibritumomab Biosimilar)

Classe de substances: Biosimilar

Sujet: Ibritumomab is a monoclonal antibody directed against the CD20 antigen found on pre-B and mature B lymphocytes (normal and malignant). Ibritumomab binding induces apoptosis in B lymphocytes in vitro. It is combined with the chelator tiuxetan, which acts as a specific chelation site for Yttrium-90 (Y-90). The monoclonal antibody acts as a delivery system to direct the radioactive isotope to the targeted cells, however, binding has been observed in lymphoid cells throughout the body and in lymphoid nodules in organs such as the large and small intestines. beta-emission induces cellular damage through the formation of free radicals (in both target cells and surrounding cells).